Geschatte realtime
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
1,735 USD | +2,06% | -0,86% | -26,60% |
28/03 | XERIS BIOPHARMA HOLDINGS, INC. : Oppenheimer verhoogt advies van Neutraal naar Kopen | ZM |
06/03 | Transcript : Xeris Biopharma Holdings, Inc., Q4 2023 Earnings Call, Mar 06, 2024 |
Omzet 2024 * | 184 mln. 172 mln. | Omzet 2025 * | 219 mln. 205 mln. | Marktkapitalisatie | 252 mln. 236 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -55 mln. -51,41 mln. | Nettowinst (verlies) 2025 * | -27 mln. -25,24 mln. | EV/omzet 2024 * | 1,37 x |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 1,15 x |
K/w-verhouding 2024 * |
-4,42
x | K/w-verhouding 2025 * |
-9,27
x | Werknemers | 377 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 96,26% |
Recentste transcriptie over Xeris Biopharma Holdings, Inc.
1 dag | +1,47% | ||
1 week | -0,86% | ||
Lopende maand | -21,95% | ||
1 maand | -15,85% | ||
3 maanden | -30,72% | ||
6 maanden | +3,92% | ||
Lopend jaar | -26,60% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Founder | 60 | 01-01-05 | |
Paul Edick
CEO | Chief Executive Officer | 67 | 05-10-21 |
Steven Pieper
DFI | Director of Finance/CFO | 47 | 01-01-21 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
John Johnson
BRD | Director/Board Member | 66 | 05-10-21 |
Jeffrey Sherman
BRD | Director/Board Member | 69 | 05-10-21 |
Marla Persky
BRD | Director/Board Member | 68 | 05-10-21 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.00% | 9 M€ | +5,51% | - | |
0.00% | 147 M€ | +4,88% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
26-04-24 | 1,725 | +1,47% | 664 725 |
25-04-24 | 1,7 | -3,41% | 894 039 |
24-04-24 | 1,76 | -1,12% | 712 941 |
23-04-24 | 1,78 | 0,00% | 1 345 307 |
22-04-24 | 1,78 | +2,30% | 1 319 079 |
uitgestelde koers Nasdaq, 26 april 2024 om 21:44 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-26,60% | 252 mln. | |
+25,95% | 653 mld. | |
+27,00% | 556 mld. | |
-6,71% | 354 mld. | |
+20,34% | 331 mld. | |
+2,89% | 296 mld. | |
+13,09% | 233 mld. | |
+5,46% | 201 mld. | |
-9,61% | 193 mld. | |
-5,91% | 144 mld. |